Ludwig, E
Phase 2 and Phase 3 trials leading to FDA approval studied its effects on sexual desire, arousal, and distress in women with HSDD, with statistically significant improvements versus placebo on the Female Sexual Function Index
When to Talk with Your Healthcare Provider PlexusDx provides educational information about genetic predispositions and possible ways to support biochemical pathways
doi: 10.1194/jlr.M064469 52 ZhengWReemREOmarovaSHuangSDiPatrePLCharvetCDet al
A note on GLP-1 agonists for weight loss Though GLP-1 agonists can be beneficial for weight loss, its important to keep in mind that there is limited research on the long-term effects of these medications
Suto, T., Fukuda, M., Ito, M., Uehara, T